IMNN:NASDAQ, Imunon, Inc.

Why IMNN stock fell on November 10

Imunon, Inc. fell 12.5% on Tuesday, November 10, 2026, on 243,700 shares. No headline about IMNN came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

IMNN stock overview

Imunon, Inc. (IMNN:NASDAQ) closed at $0.594 on November 16, 2026, down 5.56% on the day. The stock trades 86.3% below its 52-week high of $4.35 and 18.8% above its 52-week low of $0.500. Over the past year, it lost 85.5%. Imunon, Inc. is part of the Health Care sector.

Key figures

Price
$0.594
Day change
-5.56%
Volume
132,736
Average volume
150,360
Market cap
3M+
52-week range
$0.500 – $4.35
50-day average
$1.15
200-day average
$2.10

Price action over the past year

In 252 trading sessions since November 14, 2025, IMNN closed higher on 86 days (34%). Its best day was October 21, 2026 (+17.82%) and its worst was October 27, 2026 (-28.46%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

IMNN news

About Imunon, Inc.

Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

Similar stocks

Find more stocks like IMNN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.